Disclosed are 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid amides that bind t o the benzodiazepine site of GABAA receptors. Such compounds can be used to modulate ligand binding to GABAA receptors in vivo and in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) disorders in humans, domesticated companion animals, and livestock animals.
1H-PYRROLO[3,2-B]PYRIDINE-3-CARBOXYLIC ACID AMIDES